daily treatment of recipient rats with trans-4- ( aminomethyl ) cyclohexanecarboxylic acid , a synthetic product that specifically inhibits plasminogen activator derived from endothelial cells , results in marked reduction of increased permeability of the bbb and suppression of clinical signs of eae .
C0032144
plasminogen activator
C0225336
endothelial cells